We are excited to present an extended version of our tool to identify combinatorial receptor-mediated treatments from scRNA-seq of tumors. We analyzed CAR-T targets currently in trials & published ligand-mimicking peptides to identify promising candidates.
https://t.co/d7loCNN2PN
Attention!
Are you or do you know any medicinal. chemists?
What about computational chemists?
Interested in working with @exscientiaAI?
We have positions at both our Oxford and Miami locations!
Too many links, DM me for details and please RT!
Struggling to get my account on my other devices. Apparently it's not linked to any email so I can't reset the password I don't remember. Will have to make a new one and hope people migrate!
"Barrish says the steady influx of venture capital into biotech is fueling job creation. 'But I think it’s more than that,' he says. 'I think there is a renaissance in small-molecule drug discovery'."
Delighted to share this new set of #BRET-based G protein #biosensors with the #GPCR community!
Our paper's just out @scisignal and the entire toolkit is available from @Addgene!
PS: You only need to transfect a single plasmid per sensor 🧬
https://t.co/qCPXZ981Le
The team continues to grow!
Whether you're a clever GPCR scientist and want to learn drug discovery, or a passionate drug hunter and ready to fall in love with GPCRs, feel free to submit your CV and cover letter to us at Exscientia!
https://t.co/FUynpcaue5
Have been locked out of my Twitter account for a while. I can access it on my old phone. I guess I don't have an email associated with it? Trying to get general access back but will use this for the time being.
Expect rare tweets.
Milestones in the development and implementation of FRET-based sensors of intracellular signals: A biological perspective of the history of FRET
https://t.co/5At4rsW77L